Company Description
Rejection hurts, but organ transplant rejection hurts worse, and XDx wants to help. The company develops tests that monitor for cellular rejection...
Key XDx Financials
| Company Type | Private - NASDAQ (GM): XDXI Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $2.9 |
| 2006 Employees | 107 |
More XDx Financials (4 pages)
Latest XDx Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about XDx's competition across multiple industries
Top XDx Competitors
Sponsored Links
The Business Directory
XDx Executives
| Title | Name & Bio | Contact |
|---|---|---|
| VP, Corporate Development | Dirk Lammerts | Network | E-mail |
| President, CEO, and Director | Pierre Cassigneul | Network | E-mail |
| CFO | Jay M. Moyes | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current XDx News
- [DIAG]-Financings roundup: Pediatrix gets $350M facility; Pathwork closes on $20 million [AHC Newsletters] (11 Sep 2008 00:01:00 EDT)
- [MDW]-Financings roundup: XDx withdraws $86.3M IPO; Alcon to repurchase shares [AHC Newsletters] (10 Sep 2008 00:01:00 EDT)
- BioWorld Today September 9, 2008 [BioWorld Today] (09 Sep 2008 00:01:00 EDT)
Sponsored Opportunity
